PATH launches report to help safeguard pregnant women with essential medicines

PATH’s latest report Safeguarding pregnant women with essential medicines offers a targeted agenda for action for global and national advocates, policymakers, and program implementers to increase the quality and availability of oxytocin, misoprostol, and magnesium sulfat. Read the full report.